876 / 1631
Survival Rates among All Eligible Patients Who Underwent Randomization.
…may improve PFS for poorer prognosis patients (not OS)
PFS
OS
All patients high or high-intermediate IPI
Stiff PJ et al. N Engl J Med 2013;369:1681-1690
Similar findings in Italian DLCL04 Study
Chiappella Lancet Oncol 2017